I-AHCC (i-hexose esebenzayo ehlanganisiwe) iyinhlobo yemvelo ekhishwe kwezinye izinhlobo ze-basidiomycetes (isigaba samakhowe ahlanganisa shiitake). Kutholakala ngefomu lokuxhaswa, i-AHCC yaziwa njenge-antioxidant. Ngenkathi ucwaningo lwemiphumela yezempilo ye-AHCC lungafinyeleli kahle, abasekela bathi ukuthatha i-AHCC kungaveza izinzuzo ezihlukahlukene zezempilo.
Sebenzisa i-AHCC
Ngokwelashwa okunye, i-AHCC kuthiwa ivuselele amasosha omzimba futhi ikhulise ukuvikela kwakho ngokutheleleka kwegciwane, kuhlanganise nomkhuhlane kanye nomkhuhlane ovamile . Abagqugquzeli abaningi basikisela nokuthi i-AHCC ingasiza ekuvikeleni umdlavuza futhi unciphise imiphumela emibi ye-chemotherapy. Ngaphezu kwalokho, kusho i-AHCC ukusiza ukuvimbela isifo senhliziyo nokuphatha isifo sofuba.
Izinzuzo zezempilo ze-AHCC
Kuze kube manje, ukuhlolwa okuncane kwemitholampilo kuye kwahlola imiphumela yezempilo ye-AHCC. Noma kunjalo, olunye ucwaningo lokuqala lubonisa ukuthi i-AHCC inganikeza izinzuzo ezithile zezempilo. Nakhu ukubuka okutholakala okuyinhloko okuvela ocwaningweni olutholakalayo:
1) Uhlelo lwe-Immune
I-AHCC ingasiza ekukhuliseni i-immunity, ngokuya kwesilingo esincane semithi yomtholampilo ka-2008 ku- Nutrition and Cancer . Ukuze kuhlolwe, izisebenzi zokuzithandela ezingu-21 zithatha isamba se-AHCC noma i-placebo nsuku zonke amaviki amane. Ekupheleni kokucwaninga, amalungu eqembu le-AHCC abonise ukwanda okukhulu kakhulu kwinani lamaseli e-dendritic (uhlobo lweseli elihilelekile ekuphenduleni komzimba).
2) Imiphumela ye-Chemotherapy Side Effects
Ukucwaninga kwezilwane kubonisa ukuthi i-AHCC ingasiza ekunciphiseni imiphumela eminye yemiphumela ye-chemotherapy. Ngokwesibonelo, ngombiko ka-2009 ovela kuyi- Journal of Experimental Therapeutics and Oncology , ososayensi bathola ukuthi ukwelapha amagundane nge-AHCC kwawasiza ekuvikeleni ukulimala kwesibindi samakhemikhali kanye nokuncipha kwamathambo.
Kodwa-ke, kusheshe ukutshela ukuthi i-AHCC ingasiza yini ekunciphiseni imithwalo yemiphumela yamakhemikhali emzimbeni kubantu.
3) Igciwane
I-AHCC ingasiza ekuvimbeleni ukuthuthukiswa komdlavuza, ngokusho kwesifundo sezilwane esise-2006 eCancer Immunology and Immunotherapy . Esikhathini sokuhlolwa okubandakanya amagundane angenawo amagciwane omdlavuza, ukwelashwa kwe-AHCC kwandise kakhulu ukuphendula kwamagciwane kanye nokuphuza ukuthuthukiswa kwesisu.
4) Izifo zesisu sezikhukhumeza
I-AHCC ibonisa isithembiso ekwelapheni kwesifo sofuba esiswini. Esifundweni sika-2007 ngamagundane (I- Journal of Nutrition ), abacwaningi bathola ukuthi i-AHCC yasiza ukunciphisa ukuvuvukala nokuthuthukiswa kwamakhamera amaningi empilo yamakholoni emagatsini ane- colitis .
5) Umkhuhlane
Ekuvivinyweni kwamagundane, ososayensi baye babonisa ukuthi i-AHCC ingasiza ekuvuseleleni izimpendulo zokuzivikela omzimba ekuthelelekeni komkhuhlane. Isibonelo, ngo-2006 isifundo se- Journal of Nutrition , i-AHCC yabonakala ukunciphisa ubunzima bokutheleleka komkhuhlane kanye nokuqinisa umsebenzi kumangqamuzana ombulali wemvelo (umdlali omkhulu ekuphenduleni kwe-immune) kumagundane anesifo sengculaza.
Amapulangwe
Okuncane okuyaziwa ngokuphepha kokusetshenziswa kwesikhathi eside kwe-AHCC. Kodwa-ke, kunokukhathazeka okuthile ukuthi i-AHCC ingabangela imiphumela emibi emibi, kuhlanganise nesifo sohudo kanye nokushaya.
Lapho Uzoyithola khona
Etholakala kakhulu ukuthengwa ku-intanethi, izithako ze-AHCC zithengiswa ezitolo eziningi zemvelo nezitolo ezitholakala ngokukhethekile ezakhiweni zokudla.
Ukusebenzisa i-AHCC yezeMpilo
Ngenxa yokuntuleka kocwaningo olusekelayo, kusheshe kakhulu ukutusa i-AHCC nganoma yisiphi isimo sezempilo. Ngaphezu kwalokho, abukho ubufakazi obanele bokusekela isimangalo sokuthi i-AHCC ingavimbela umdlavuza. Ukunciphisa ingozi yomdlavuza wakho jikelele, iNational Cancer Institute itusa ukuba ugweme ukubhema ugwayi nokusetshenziswa kogwayi; ukunciphisa ukuvezwa kwakho emisebeni, futhi uhlolwe izimo zangaphambi komdlavuza. Ukulandela ukudla okunempilo, ukuzivocavoca njalo nokugcina isisindo esivamile kungasiza ekuvimbeleni umdlavuza.
Uma ucabangela ukusebenzisa i-AHCC ngesimo esingapheli, qiniseka ukuthi uxhumana nodokotela wakho.
Ukwelapha isimo esingapheli nge-AHCC nokugwema noma ukubambezela ukunakekelwa okujwayelekile kungaba nemiphumela emibi kakhulu.
Imithombo
U-Daddaoua A, Martínez-Plata E, uLópez-Posadas R, Vieites JM, González M, Requena P, Zarzuelo A, Suárez MD, kaMedina FS, uMartínez-Augustin O. "I-hexose esebenzayo ehlanganisiwe ibhekwa njenge-prebiotic futhi ayinakuphikisa amagundane ane-hapten-induced colitis. " J Nutriti. 2007 Meyi; 137 (5): 1222-8.
I-Gao Y, i-Zhang D, i-Sun B, i- Fujii H, i-Kosuna K, i-Yin Z. "I-hexose esebenzayo ehlanganisiwe ikhulisa ukubhekwa kwe-tumor ngokulawula kokubili izimpendulo ze-immune ezingenasici nezingaguquguquki." I-Cancer Immunol Immunother. 2006 Oct; 55 (10): 1258-66.
I-National Cancer Institute. "Sibutsetelo sokuvimbela umdlavuza." Kugcine ukutholakala ngo-February 13, 2012.
Nogusa S, Gerbino J, Ritz BW. "Ukwesekwa okuncane kwe-dose ne-hexose esebenzayo ehlanganisiwe kuthuthukisa indlela yokuzivikela komzimba ekutheleleni ukutheleleka kwe-influenza ku-C57BL / 6 amagundane." I-Nutr Res. 2009 Feb; 29 (2): 139-43.
Ritz BW, Nogusa S, Ackerman EA, Gardner EM. "Ukwengezwa nge-hexose esebenzayo yinkimbinkimbi ikhulisa impendulo yegciwane lesandulela ngculaza yamagundane amancane ekuthelelekeni komkhuhlane omkhulu." J Nutriti. 2006 no-Nov; 136 (11): 2868-73.
Shigama K, Nakaya A, Wakame K, Nishioka H, Fujii H. "Ukunciphisa ukusebenza kwe-hexose ehlanganisiwe ehlanganisiwe (AHCC) yemiphumela emibi eyenziwa izidakamizwa ezinkambeni ezingenayo i-tumor." J Exp Ther Oncol. 2009; 8 (1): 43-51.
Takahashi K, Yamamoto T, Yamao J, Takai S, Kwon AH, Kamiyama Y. "Umthelela omzimba we-hexose esebenzayo ehlanganisiwe (AHCC) emavolontiya aphilile: i-double blind-blind, isilingo esilawulwa yi-placebo. " I-Cancer Cancer. 2008; 60 (5): 643-51.